Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jul 15;317(Pt 2):565–570. doi: 10.1042/bj3170565

Cyclophilin B mediates cyclosporin A incorporation in human blood T-lymphocytes through the specific binding of complexed drug to the cell surface.

F Allain 1, A Denys 1, G Spik 1
PMCID: PMC1217523  PMID: 8713086

Abstract

Cyclophilin B (CyPB) is a cyclosporin A (CsA)-binding protein located within intracellular vesicles and released in biological fluids. We recently reported the specific binding of this protein to T-cell surface receptor which is internalized even in the presence of CsA. These results suggest that CyPB might target the drug to lymphocytes and consequently modify its activity. To verify this hypothesis, we have first investigated the binding capacity and internalization of the CsA-CyPB complex in human peripheral blood T-lymphocytes and secondly compared the inhibitory effect of both free and CyPB-complexed CsA on the CD3-induced activation and proliferation of T-cells. Here, we present evidence that both the CsA-CyPB complex and free CyPB bind to the T-lymphocyte surface, with similar values of Kd and number of sites. At 37 degrees C, the complex is internalized but, in contrast to the protein, the drug is accumulated within the cell. Moreover, CyPB receptors are internalized together with the ligand and rapidly recycled to the cell surface. Finally, we demonstrate that CyPB-complexed CsA remains as efficient as uncomplexed CsA and that CyPB enhances the immunosuppressive activity of the drug. Taken together, our results support the hypothesis that surface CyPB receptors may be related to the selective and variable action of CsA, through specific binding and targeting of the CyPB-CsA complex to peripheral blood T-lymphocytes.

Full Text

The Full Text of this article is available as a PDF (427.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain F., Boutillon C., Mariller C., Spik G. Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies. J Immunol Methods. 1995 Jan 13;178(1):113–120. doi: 10.1016/0022-1759(94)00249-v. [DOI] [PubMed] [Google Scholar]
  2. Allain F., Denys A., Spik G. Characterization of surface binding sites for cyclophilin B on a human tumor T-cell line. J Biol Chem. 1994 Jun 17;269(24):16537–16540. [PubMed] [Google Scholar]
  3. Arber S., Krause K. H., Caroni P. s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J Cell Biol. 1992 Jan;116(1):113–125. doi: 10.1083/jcb.116.1.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker E. K., Colley N. J., Zuker C. S. The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J. 1994 Oct 17;13(20):4886–4895. doi: 10.1002/j.1460-2075.1994.tb06816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bergsma D. J., Eder C., Gross M., Kersten H., Sylvester D., Appelbaum E., Cusimano D., Livi G. P., McLaughlin M. M., Kasyan K. The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J Biol Chem. 1991 Dec 5;266(34):23204–23214. [PubMed] [Google Scholar]
  6. Bram R. J., Crabtree G. R. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature. 1994 Sep 22;371(6495):355–358. doi: 10.1038/371355a0. [DOI] [PubMed] [Google Scholar]
  7. Cacalano N. A., Chen B. X., Cleveland W. L., Erlanger B. F. Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4353–4357. doi: 10.1073/pnas.89.10.4353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F. X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989 Feb 2;337(6206):476–478. doi: 10.1038/337476a0. [DOI] [PubMed] [Google Scholar]
  9. Foxwell B. M., Woerly G., Husi H., Mackie A., Quesniaux V. F., Hiestand P. C., Wenger R. M., Ryffel B. Identification of several cyclosporine binding proteins in lymphoid and non-lymphoid cells in vivo. Biochim Biophys Acta. 1992 Feb 14;1138(2):115–121. doi: 10.1016/0925-4439(92)90050-w. [DOI] [PubMed] [Google Scholar]
  10. Gupta A. K., Baadsgaard O., Ellis C. N., Voorhees J. J., Cooper K. D. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch Dermatol Res. 1989;281(4):219–226. doi: 10.1007/BF00431054. [DOI] [PubMed] [Google Scholar]
  11. Haendler B., Hofer-Warbinek R., Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J. 1987 Apr;6(4):947–950. doi: 10.1002/j.1460-2075.1987.tb04843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hasel K. W., Glass J. R., Godbout M., Sutcliffe J. G. An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol. 1991 Jul;11(7):3484–3491. doi: 10.1128/mcb.11.7.3484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  14. Kieffer L. J., Seng T. W., Li W., Osterman D. G., Handschumacher R. E., Bayney R. M. Cyclophilin-40, a protein with homology to the P59 component of the steroid receptor complex. Cloning of the cDNA and further characterization. J Biol Chem. 1993 Jun 15;268(17):12303–12310. [PubMed] [Google Scholar]
  15. Liu J., Albers M. W., Wandless T. J., Luan S., Alberg D. G., Belshaw P. J., Cohen P., MacKintosh C., Klee C. B., Schreiber S. L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 1992 Apr 28;31(16):3896–3901. doi: 10.1021/bi00131a002. [DOI] [PubMed] [Google Scholar]
  16. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  17. Masy E., Labalette-Houache M., Dessaint J. P. Individual differences in the in vitro response to cyclosporin A (CsA): possible heterogeneity in the involvement of the CD28-B7/BB1 pathway. Therapie. 1994 May-Jun;49(3):271–277. [PubMed] [Google Scholar]
  18. Povlsen J. V., Rasmussen A., Madsen M., Lamm L. U. Ciclosporin-induced immunosuppression in vitro. II. Variation in sensitivity and binding capacity. Scand J Immunol. 1990 Jul;32(1):45–51. doi: 10.1111/j.1365-3083.1990.tb02890.x. [DOI] [PubMed] [Google Scholar]
  19. Price E. R., Jin M., Lim D., Pati S., Walsh C. T., McKeon F. D. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3931–3935. doi: 10.1073/pnas.91.9.3931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Price E. R., Zydowsky L. D., Jin M. J., Baker C. H., McKeon F. D., Walsh C. T. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1903–1907. doi: 10.1073/pnas.88.5.1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sander B., Brigati C., Möller E. Inhibition of in vitro alloreactivity by cyclosporin A: evidence for an inter-individual variation in sensitivity. Scand J Immunol. 1986 Apr;23(4):435–440. doi: 10.1111/j.1365-3083.1986.tb03075.x. [DOI] [PubMed] [Google Scholar]
  22. Schneider H., Charara N., Schmitz R., Wehrli S., Mikol V., Zurini M. G., Quesniaux V. F., Movva N. R. Human cyclophilin C: primary structure, tissue distribution, and determination of binding specificity for cyclosporins. Biochemistry. 1994 Jul 12;33(27):8218–8224. doi: 10.1021/bi00193a007. [DOI] [PubMed] [Google Scholar]
  23. Schreiber S. L. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell. 1992 Aug 7;70(3):365–368. doi: 10.1016/0092-8674(92)90158-9. [DOI] [PubMed] [Google Scholar]
  24. Sherry B., Yarlett N., Strupp A., Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3511–3515. doi: 10.1073/pnas.89.8.3511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Smith T., Ferreira L. R., Hebert C., Norris K., Sauk J. J. Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum. J Biol Chem. 1995 Aug 4;270(31):18323–18328. doi: 10.1074/jbc.270.31.18323. [DOI] [PubMed] [Google Scholar]
  26. Spik G., Haendler B., Delmas O., Mariller C., Chamoux M., Maes P., Tartar A., Montreuil J., Stedman K., Kocher H. P. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem. 1991 Jun 15;266(17):10735–10738. [PubMed] [Google Scholar]
  27. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 1989 Feb 2;337(6206):473–475. doi: 10.1038/337473a0. [DOI] [PubMed] [Google Scholar]
  28. Xu Q., Leiva M. C., Fischkoff S. A., Handschumacher R. E., Lyttle C. R. Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 1992 Jun 15;267(17):11968–11971. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES